Incredible Growth Predicted for Advanced Clinical Decision Support Platforms Market 2031
The advanced clinical decision support platforms market is estimated to reach $1,175.0 million by 2031, growing at a CAGR of 9.0% from 2022 to 2031
PORTLAND, OREGON, UNITED STATES, April 14, 2023 /EINPresswire.com/ -- ๐๐ง๐ญ๐ซ๐จ๐๐ฎ๐๐ญ๐ข๐จ๐ง:
Clinical decision support systems (CDSS) are computer-based tools that assist healthcare providers in making clinical decisions by providing relevant patient information and knowledge. These systems are designed to improve clinical decision-making, reduce medical errors, and improve patient outcomes. Advanced CDSS platforms are the next generation of CDSS systems that leverage advanced technologies such as artificial intelligence (AI) and machine learning (ML) to provide more personalized and efficient clinical decision support.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐ฉ๐๐๐ญ๐๐ ๐๐๐ซ๐ฌ๐ข๐จ๐ง 2023: https://www.alliedmarketresearch.com/request-sample/13465
๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
โขCAGR: 8.7%
โข Current Market Size: USD 0.45 Billion
โข Forecast Growing Region: APAC
โข Largest Market: North America
โข Projection Time: 2021- 2031
โข Base Year: 2021
The advanced clinical decision support platforms market size was valued at $496.4 million in 2021, and is estimated to reach $1,175.0 million by 2031, growing at a CAGR of 9.0% from 2022 to 2031.The increasing demand for personalized medicine, the rising prevalence of chronic diseases, and the need to reduce healthcare costs are some of the key factors driving the market growth.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
The advanced clinical decision support platforms market share is segmented into Type, Model, Setting, and Region. By type, the market is bifurcated into therapeutic and diagnostic. The diagnostic segment is further divided into hospitals and ambulatory care. Therapeutic segment is further classified into hospitals and ambulatory care. By model, the market is categorized into knowledge based and non-knowledge based. By setting, the market is segregated into hospital and ambulatory care. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
North America dominates the global advanced clinical decision support platforms market, owing to the presence of well-established healthcare infrastructure, high adoption of advanced technologies, and the presence of major market players in the region. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing healthcare expenditure, rising prevalence of chronic diseases, and increasing government initiatives to promote healthcare IT adoption.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ฉ๐๐ซ๐๐ญ๐ข๐ง๐ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐ฏ๐๐ง๐๐๐ ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐๐๐ข๐ฌ๐ข๐จ๐ง ๐ฌ๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ ๐ฉ๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐
โข Oracle Corporation,
โข Wolters Kluwer,
โข Meditech,
โข IBM Watson Health,
โข Veradigm Inc.,
โข Epic Systems Corporation,
โข NextGen Healthcare Inc.,
โข Zynx health,
โข Siemens Healthineers,
โข Relx Group
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (241 ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @ https://www.alliedmarketresearch.com/advanced-clinical-decision-support-platforms-market/purchase-options
๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐จ๐ฏ๐ข๐-19 ๐จ๐ง ๐๐๐ฏ๐๐ง๐๐๐ ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐๐๐ข๐ฌ๐ข๐จ๐ง ๐๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ ๐๐ฅ๐๐ญ๐๐จ๐ซ๐ฆ๐ฌ ๐๐๐ซ๐ค๐๐ญ-
The COVID-19 pandemic had a positive impact on the advanced clinical decision support platform market, as the demand for advanced clinical decision support platform increased slightly due to the increased need for accurate and timely clinical decision making during the pandemic.
The demand for advanced clinical decision support platform surged due to the increasing demand for remote patient care and telehealth services. Advanced clinical decision support platform has enabled healthcare providers to make more informed decisions about patient care and provide better treatment options. In addition, advanced clinical decision support platform allowed healthcare providers to provide more efficient and accurate clinical decision making for patient care.
๐๐จ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ - https://www.alliedmarketresearch.com/purchase-enquiry/13465
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ โ
๐๐จ๐ญ๐ฎ๐ฅ๐ข๐ง๐ฎ๐ฆ ๐๐จ๐ฑ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ- https://www.alliedmarketresearch.com/botulinum-toxin-market-A11935
๐๐ฅ๐จ๐ฏ๐๐ฌ ๐๐๐ซ๐ค๐๐ญ - https://www.alliedmarketresearch.com/gloves-market-A08867
๐๐ง๐๐ฎ๐ฆ๐จ๐ง๐ข๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ- https://www.alliedmarketresearch.com/pneumonia-therapeutics-market-A11230
David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
